Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Proceedings of Osteorheumatology 2011: International Congress on Bone Involvement in Arthritis

Meeting abstract

Subchondral bone remodelling and osteoarthritis

Jorge A Román-Blas1*, Santos Castañeda2, Raquel Largo1 and Gabriel Herrero-Beaumont1

  • * Corresponding author: Jorge A Román-Blas

Author affiliations

1 Bone and Joint Research Unit, Service of Rheumatology, IIS Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain

2 Department of Rheumatology, Hospital de la Princesa, IIS Princesa, Universidad Autónoma, Madrid, Spain

For all author emails, please log on.

Citation and License

Arthritis Research & Therapy 2012, 14(Suppl 2):A6  doi:10.1186/ar3713

The electronic version of this article is the complete one and can be found online at: http://arthritis-research.com/content/14/S2/A6


Published:8 March 2012

© 2012 Román-Blas et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Meeting abstract

Osteoarthritis (OA) emerges of the inharmonious functioning of joint tissues, particularly subchondral bone (SB) and articular cartilage that are two mechanically and biologically intertwined tissues [1]. Thus, biomechanical, biochemical and/or genetic alterations affecting any joint tissue may cause anomalous intra-articular stresses and subsequent tissue damage associated to a failure of repair [2]. Specific anatomical regions have been described in the bone underlying joint cartilage, including the subchondral cortical plate, subchondral trabecular bone and sub-articular bone [3]. Each region likely contributes differently to cartilage pathology. However, a lack of clear boundaries between these tissues by current imaging techniques generates some confusion in their study and thorough research will help to improve our understanding of SB properties. In addition, bone at the joint margins is markedly active since is the site of osteophyte development in OA. The close relationship between SB and joint cartilage evokes an unanswered question with valuable therapeutic implications [4]. In this context, the relationship among SB microstructure and remodeling, and cartilage destruction becomes important.

Yet, it remains controversial whether SB alterations precede the cartilage damage or they further appear during the evolution of the disease. In fact, SB remodeling abnormalities, especially increased bone turnover, have been detected early in the evolution of some forms of OA in animal models [5,6] and humans [7,8]. On the other hand, OA and systemic osteoporosis (OP) share a paradoxical relationship, being probable that high as well as low bone mass conditions result in induction and/or OA progression [4]. Interestingly, improving SB integrity showed to reduce the progression of cartilage damage in an animal model of OA preceded by OP [9]. Therefore, both bone mass phenotypes may be considered risk factors for OA initiation. The presence of other risk factors such as skeletal shape abnormalities, joint overload or obesity may have a synergistic effect for OA initiation. In addition, inflammatory mediators released by the articular cartilage may lead to SB loss by increasing bone remodeling in OA. Accordingly, OA treatment goals must consider the improvement of SB integrity. This therapeutic approach should be individualized depending on the patient BMD status and OA phenotype, and subsequently the use of drugs should also be individualized for each patient [10]. Recent findings suggest that the same drugs could be useful for treating simultaneously both processes, at least in a subgroup of patients with OA and concomitant OP.

References

  1. Goldring MB, Goldring SR: Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis.

    Ann NY Acad Sci 2010, 1192:230-237. PubMed Abstract | Publisher Full Text OpenURL

  2. Lane NE, Brandt K, Hawker G, et al.: OARSI-FDA initiative: defining the disease state of osteoarthritis.

    Osteoarthritis Cartilage 2011, 19:478-482. PubMed Abstract | Publisher Full Text OpenURL

  3. Burr DB: Anatomy and physiology of the mineralized tissues: role in the pathogenesis of osteoarthrosis.

    Osteoarthritis Cartilage 2004, 12(Suppl A):S20-S30. PubMed Abstract | Publisher Full Text OpenURL

  4. Herrero-Beaumont G, Roman-Blas JA, Largo R, et al.: Bone mineral density and joint cartilage: four clinical settings of a complex relationship in osteoarthritis.

    Ann Rheum Dis 2011, 70:1523-1525. PubMed Abstract | Publisher Full Text OpenURL

  5. Pastoureau PC, Chomel AC, Bonnet J: Evidence of early subchondral bone changes in the meniscectomized guinea pig. A densitometric study using dual-energy X-ray absorptiometry subregional analysis.

    Osteoarthritis Cartilage 1999, 7:466-473. PubMed Abstract | Publisher Full Text OpenURL

  6. Hayami T, Pickarski M, Zhuo Y, et al.: Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis.

    Bone 2006, 38:234-243. PubMed Abstract | Publisher Full Text OpenURL

  7. Day JS, Ding M, van der Linden JC, et al.: A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage.

    J Orthop Res 2001, 19:914-918. PubMed Abstract | Publisher Full Text OpenURL

  8. Hochberg MC, Lethbridge-Cejku M, Scott WW Jr, et al.: Upper extremity bone mass and osteoarthritis of the knees: data from the Baltimore Longitudinal Study of Aging.

    J Bone Miner Res 1995, 10:432-438. PubMed Abstract | Publisher Full Text OpenURL

  9. Bellido M, Lugo L, Roman-Blas JA, et al.: Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis.

    Osteoarthritis Cartilage 2011, 19:1228-1236. PubMed Abstract | Publisher Full Text OpenURL

  10. Castañeda S, Roman-Blas JA, Largo R, et al.: Subchondral bone as a key target for osteoarthritis treatment.

    Biochem Pharmacol 2011, 83:315-323. PubMed Abstract | Publisher Full Text OpenURL